Metformin for the treatment of the polycystic ovary syndrome

被引:197
|
作者
Nestler, John E.
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 01期
关键词
D O I
10.1056/NEJMct0707092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 23- year- old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual periods per year and is not interested in becoming pregnant now, but she will be getting married in a year. She has heard that the polycystic ovary syndrome is associated with diabetes and is concerned because both her mother and father have type 2 diabetes. Her body-mass index ( the weight in kilograms divided by the square of the height in meters) is 32, her waist circumference is 38 in. ( 96.5 cm), her serum total testosterone level is elevated at 0.9 ng per milliliter ( 90 ng per deciliter, or 2.9 nmol per liter), her plasma high- density lipoprotein cholesterol level is 35 mg per deciliter ( 0.9 mmol per liter), and her triglyceride level is 190 mg per deciliter ( 2.1 mmol per liter). Her serum glucose level 2 hours after the ingestion of 75 g of dextrose is 138 mg per deciliter ( 7.7 mmol per liter). The physician wonders whether treatment with metformin would be beneficial and refers the patient to an endocrinologist.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [21] Prediction of the effect of metformin treatment in patients with polycystic ovary syndrome
    Vrbíková, J
    Hill, M
    Stárka, L
    Vondra, K
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2002, 53 (02) : 100 - 104
  • [22] Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome
    Daneshjou, Delbar
    Mehranjani, Malek Soleimani
    Modarres, Shahrzad Zadeh
    Shariatzadeh, Mohammad Ali
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2020, 31 (12): : 890 - 892
  • [23] Metformin, diet and polycystic ovary syndrome
    不详
    DIABETES OBESITY & METABOLISM, 2001, 3 (01): : 55 - 56
  • [24] Metformin in polycystic ovary syndrome - Reply
    Nestler, John E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (17): : 1868 - 1868
  • [25] Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome
    Tarkun, Ilhan
    Dikmen, Emre
    Cetinarslan, Berrin
    Canturk, Zeynep
    EUROPEAN CYTOKINE NETWORK, 2010, 21 (04) : 272 - 277
  • [26] Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome (PCOS)
    Jude, Edward
    Postolopoulos, N. A.
    Berry, R.
    Watson, A.
    Mohiyiddeen, L.
    DIABETES, 2007, 56 : A155 - A155
  • [27] Metformin for adolescents with polycystic ovary syndrome
    Ying-hua LIU
    Li-hui HOU
    Yan LI
    Ming LIU
    Fang XU
    Ying WANG
    Journal of Reproduction and Contraception, 2015, (02) : 103 - 111
  • [28] Use of metformin in polycystic ovary syndrome
    Koch, YD
    Ernst, ME
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1644 - 1647
  • [29] Metformin therapy in polycystic ovary syndrome
    Jakimiuk, Artur J.
    GINEKOLOGIA POLSKA, 2008, 79 (01) : 8 - 11
  • [30] Metformin and intervention in polycystic ovary syndrome
    Norman, RJ
    Kidson, WJ
    Cuneo, RC
    Zacharin, MR
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (11) : 580 - +